Joshua Salomon of Stanford Health Policy

Joshua Salomon, PhD

  • Professor, Health Policy
  • Senior Fellow, Freeman Spogli Institute for International Studies
Encina Commons Room 114, 615 Crothers Way, Stanford, CA 94305-6006
(650) 736-9477 (voice)

Biography

Joshua Salomon is a Professor of Health Policy in the Stanford University School of Medicine and a Senior Fellow at the Center for Health Policy in the Freeman Spogli Institute for International Studies. His research focuses on priority-setting in global health, within three main substantive areas: (1) measurement and valuation of health outcomes; (2) modeling patterns and trends in major causes of global mortality and disease burden; and (3) evaluation of health interventions and policies.

Dr. Salomon is an investigator on projects funded by the Centers for Disease Control, National Institutes of Health and the Bill & Melinda Gates Foundation, relating to modeling of infectious and chronic diseases and associated intervention strategies; methods for economic evaluation of public health programs; measurement of the global burden of disease; and assessment of the potential impact and cost effectiveness of new health technologies.

He is Director of the Prevention Policy Modeling Lab, which is a multi-institution research consortium that conducts health and economic modeling relating to infectious disease. Prior to joining the Stanford faculty, Dr. Salomon was Professor of Global Health at Harvard T.H. Chan School of Public Health.

publications

Journal Articles
May 2021

Impact of Treatment Duration on Mortality Among Veterans with Opioid Use Disorder in The United States Veterans Health Administration

Author(s)
Impact of Treatment Duration on Mortality Among Veterans with Opioid Use Disorder in The United States Veterans Health Administration
Journal Articles
July 2021

COVID-19 in the California State Prison System: an Observational Study of Decarceration, Ongoing Risks, and Risk Factors

Author(s)
COVID-19 in the California State Prison System: an Observational Study of Decarceration, Ongoing Risks, and Risk Factors
Journal Articles
January 2021

Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply

Author(s)
Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply

In The News

Getty Images illustration of COVID-19 vaccine vials
News

Protection Against Omicron from Vaccination and Previous Infection

Research using data from residents and staff in the California prison systems show that vaccinations offer good protection against infection with Omicron, even among patients who had previous infections.
Protection Against Omicron from Vaccination and Previous Infection
COVID-19 mask graffiti
News

Effectiveness of the COVID-19 Vaccine in One California Prison

The latest study by the Stanford Health Policy COVID-19 modeling team shows that vaccination continues to provide powerful protection from the delta variant, even among people who have been infected before.
Effectiveness of the COVID-19 Vaccine in One California Prison
COVID-19 disparities illustration
News

Stanford Researchers Document Progress, Missed Opportunities in Equitable COVID-19 Vaccine Uptake

Unequal COVID-19 vaccination rates in the United States have compounded existing disparities in cases, hospitalizations and deaths among Black and Hispanic populations. SHP researchers quantify how differential vaccine uptake by race and ethnicity within each US state produced substantial vaccination coverage disparities during the initial scale-up among older adults.
Stanford Researchers Document Progress, Missed Opportunities in Equitable COVID-19 Vaccine Uptake
Top